Sat Kartar Shopping Limited — Board Meeting, 18-04-2026: Outcome of Board Meeting

Sat Kartar Life board approved a ₹0.87 Cr preferential equity issue & ₹47.72 Cr convertible warrants issue to non-promoters, boosting its healthcare platform. The company will also acquire the remaining 24% of subsidiary Plantomed Neutraceuticals for ₹1.21 Cr, making it wholly-owned. An EGM is set for May 13 to approve these.